Figure 10 — Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Research Paper|Volume 16, Issue 10|pp. 8772–8809

Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Back to articleFigure 10(10 of 14)

100%

Figure 10.Development and evaluation of a prognostic nomogram. (A) Nomogram composed of MPPS, age, stage to predict 1-, 3-, 5-year OS probability. (B) Calibration curves of 1-, 3-, 5-year OS by nomogram. 1- (C), 3- (D), 5- (E) year ROC curves of MPPS, nomogram, age, sex, stage, and treatment type.